BioMarin Pharmaceutical Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BMRN Nasdaq 2836 www.biomarin.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioMarin Pharmaceutical Inc.

What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year - May 30th, 2026 11:56 am
BioMarin Pharmaceutical Inc. (BMRN) A Stock that Could 10x by 2030 on Pipeline Development - May 30th, 2026 10:43 am
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside - May 28th, 2026 2:27 pm
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today - May 22nd, 2026 11:00 pm
1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky - May 22nd, 2026 12:44 pm
BioMarin’s (BMRN) Phase 3 Trial of BMN 401 for ENPP1 Deficiency Meets One Co-Primary Endpoint - May 21st, 2026 7:29 am
BioMarin (BMRN) Is Down 6.3% After Mixed Phase 3 BMN 401 Results in ENPP1 Deficiency - May 20th, 2026 5:12 pm
BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia - May 20th, 2026 2:20 pm
BMRN Stock Down on Mixed Results From Rare Disease Therapy Study - May 19th, 2026 10:56 am
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls - May 19th, 2026 7:34 am
Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-Energy, and More - May 19th, 2026 6:04 am
BioMarin drug acquired in buyout misses goal in rare disease study - May 19th, 2026 5:58 am
BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency - May 18th, 2026 7:05 am
2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down - May 17th, 2026 11:32 pm
A Look At BioMarin Pharmaceutical (BMRN) Valuation As Guidance Rises And New VOXZOGO Data Emerges - May 14th, 2026 5:16 am
BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions - May 13th, 2026 5:24 pm
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer - May 13th, 2026 5:30 am
Evercore ISI Lifts PT on BioMarin Pharmaceutical Inc. (BMRN) - May 12th, 2026 3:27 pm
Dell downgraded, Uber upgraded: Wall Street's top analyst calls - May 11th, 2026 7:44 am
Here Are Monday’s Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy’s, and More - May 11th, 2026 5:58 am